Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Qingyangshen mitigates amyloid-β and Tau aggregate defects involving PPARα-TFEB activation in transgenic mice of Alzheimer's disease
Ashok Iyaswamy, Senthil Kumar Krishnamoorthi, Huan Zhang, et al.
Phytomedicine (2021) Vol. 91, pp. 153648-153648
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates Tau pathology: Implications for Alzheimer's disease therapy
Chuanbin Yang, Cheng-Fu Su, Ashok Iyaswamy, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 4, pp. 1707-1722
Open Access | Times Cited: 77
Signal pathways in the treatment of Alzheimer’s disease with traditional Chinese medicine
Min-Rui Ding, Yan-Jie Qu, Bing Hu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113208-113208
Open Access | Times Cited: 73
Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models
Ashok Iyaswamy, Xueli Wang, Senthilkumar Krishnamoorthi, et al.
Redox Biology (2022) Vol. 51, pp. 102280-102280
Open Access | Times Cited: 54
Isoliquiritigenin mitigates oxidative damage after subarachnoid hemorrhage in vivo and in vitro by regulating Nrf2-dependent Signaling Pathway via Targeting of SIRT1
Jiaqiang Liu, Xintong Zhao, Feiyun Qin, et al.
Phytomedicine (2022) Vol. 105, pp. 154262-154262
Closed Access | Times Cited: 43
Hederagenin improves Alzheimer's disease through PPARα/TFEB-mediated autophagy
Zhishen Xie, Jianping Zhao, Li-min Wu, et al.
Phytomedicine (2023) Vol. 112, pp. 154711-154711
Closed Access | Times Cited: 32
Plant-Derived Bioactive Compounds in the Management of Neurodegenerative Disorders: Challenges, Future Directions and Molecular Mechanisms Involved in Neuroprotection
Shoaib Shoaib, Mohammad Azam Ansari, Adel Al Fatease, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 749-749
Open Access | Times Cited: 32
RETRACTED: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics
Deepshi Arora, Shailendra Bhatt, Manish Kumar, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 27
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy
Jinwang Ye, Hua-Li Wan, Sihua Chen, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1489-1498
Open Access | Times Cited: 18
Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer’s Disease and Parkinson’s Disease
Jing Yang, Wei Zhang, Shugeng Zhang, et al.
Aging and Disease (2023) Vol. 14, Iss. 3, pp. 652-652
Open Access | Times Cited: 15
Cyanidin-3-O-glucoside protects the brain and improves cognitive function in APPswe/PS1ΔE9 transgenic mice model
Hana Baek, Sanjay Sanjay, Miey Park, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Effects of Qingyangshen glycosides on neuroplasticity in a mouse model of social defeat
Jingru Wang, W. Chen, Qiang Zhu, et al.
Animal Models and Experimental Medicine (2025)
Open Access
Rhynchophylline alleviates cognitive deficits in multiple transgenic mouse models of Alzheimer’s disease via modulating neuropathology and gut microbiota
Mei Zhong, Qingqing Xu, Mingqing Huang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer’s disease therapy
Sravan Gopalkrishnashetty Sreenivasmurthy, Ashok Iyaswamy, Senthilkumar Krishnamoorthi, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 26
Klotho an Autophagy Stimulator as a Potential Therapeutic Target for Alzheimer’s Disease: A Review
Tsz Kan Fung, Ashok Iyaswamy, Sravan Gopalkrishnashetty Sreenivasmurthy, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 705-705
Open Access | Times Cited: 24
Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer’s disease and tauopathy models
Karthikeyan Selvarasu, Abhay Singh, Ashok Iyaswamy, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 24
Mechanistic Insights into Selective Autophagy Subtypes in Alzheimer’s Disease
Xinjie Guan, Ashok Iyaswamy, Sravan Gopalkrishnashetty Sreenivasmurthy, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3609-3609
Open Access | Times Cited: 20
Natural Products as the Potential to Improve Alzheimer’s and Parkinson’s Disease
Sung Wook Kim, Jun Ho Lee, Bumjung Kim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8827-8827
Open Access | Times Cited: 10
Molecular engineering of a theranostic molecule that detects Aβ plaques, inhibits Iowa and Dutch mutation Aβ self-aggregation and promotes lysosomal biogenesis for Alzheimer's disease
Ashok Iyaswamy, Xueli Wang, Hailong Zhang, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 31, pp. 7543-7556
Open Access | Times Cited: 3
Unveiling the role of astrogliosis in Alzheimer’s disease Pathology: Insights into mechanisms and therapeutic approaches
Mohit Paidlewar, Sneha Kumari, Rishika Dhapola, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112940-112940
Closed Access | Times Cited: 2
Clavulanic Acid: A Novel Potential Agent in Prevention and Treatment of Scopolamine-Induced Alzheimer’s Disease
Mahdieh Anoush, Zeinab Pourmansouri, Rafi Javadi, et al.
ACS Omega (2022) Vol. 7, Iss. 16, pp. 13861-13869
Open Access | Times Cited: 13
The Potential Role of miRNA-Regulated Autophagy in Alzheimer’s Disease
Hu Zhang, Jiling Liang, Ning Chen
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7789-7789
Open Access | Times Cited: 13
Patchouli alcohol ameliorates the learning and memory impairments in an animal model of Alzheimer's disease via modulating SIRT1
Qingqing Xu, Ziren Su, Zhen Hu, et al.
Phytomedicine (2022) Vol. 106, pp. 154441-154441
Closed Access | Times Cited: 12
Pterostilbene Attenuates Subarachnoid Hemorrhage-Induced Brain Injury through the SIRT1-Dependent Nrf2 Signaling Pathway
Zihuan Zhang, Jincheng Fang, Jia-Wang Zhou, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 12
Impact and Advances in the Role of Bacterial Extracellular Vesicles in Neurodegenerative Disease and its Therapeutics
Ashok Iyaswamy, Kejia Lu, Xinjie Guan, et al.
(2023)
Open Access | Times Cited: 6
PPARɑ Ligand Caudatin Improves Cognitive Functions and Mitigates Alzheimer’s Disease Defects By Inducing Autophagy in Mice Models
Senthilkumar Krishnamoorthi, Ashok Iyaswamy, Sravan Gopalkrishnashetty Sreenivasmurthy, et al.
Journal of Neuroimmune Pharmacology (2023) Vol. 18, Iss. 3, pp. 509-528
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top